- Home
- ABEO vs MVBF Comparison
ABEO vs MVBF Comparison
Compare ABEO & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- MVBF
- Stock Information
- Founded
- ABEO N/A
- MVBF 1997
- Country
- ABEO United States
- MVBF United States
- Employees
- ABEO N/A
- MVBF N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- MVBF Major Banks
- Sector
- ABEO Health Care
- MVBF Finance
- Exchange
- ABEO Nasdaq
- MVBF Nasdaq
- Market Cap
- ABEO 243.9M
- MVBF 259.3M
- IPO Year
- ABEO 1980
- MVBF N/A
- Fundamental
- Price
- ABEO $6.52
- MVBF $18.85
- Analyst Decision
- ABEO Strong Buy
- MVBF Buy
- Analyst Count
- ABEO 3
- MVBF 2
- Target Price
- ABEO $18.00
- MVBF $27.00
- AVG Volume (30 Days)
- ABEO 245.9K
- MVBF 26.5K
- Earning Date
- ABEO 11-11-2024
- MVBF 10-24-2024
- Dividend Yield
- ABEO N/A
- MVBF 3.67%
- EPS Growth
- ABEO N/A
- MVBF N/A
- EPS
- ABEO N/A
- MVBF 1.56
- Revenue
- ABEO N/A
- MVBF $143,783,000.00
- Revenue This Year
- ABEO N/A
- MVBF N/A
- Revenue Next Year
- ABEO $7,097.06
- MVBF $8.72
- P/E Ratio
- ABEO N/A
- MVBF $11.95
- Revenue Growth
- ABEO 147.52
- MVBF 5.85
- 52 Week Low
- ABEO $3.05
- MVBF $17.51
- 52 Week High
- ABEO $9.01
- MVBF $25.24
- Technical
- Relative Strength Index (RSI)
- ABEO 67.41
- MVBF 42.28
- Support Level
- ABEO $6.06
- MVBF $18.40
- Resistance Level
- ABEO $6.48
- MVBF $19.44
- Average True Range (ATR)
- ABEO 0.32
- MVBF 0.46
- MACD
- ABEO 0.05
- MVBF -0.07
- Stochastic Oscillator
- ABEO 99.12
- MVBF 20.89
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides community banking, mortgage banking, insurance and wealth management services to individuals and corporate clients in the Mid-Atlantic region. The Bank offers its customers various products, such as checking accounts, negotiable order of withdrawal (NOW) accounts, money market and savings accounts, time certificates of deposit, commercial, installment, commercial real estate and residential real estate mortgage loans, debit cards, and safe deposit rental facilities. MVB has three reportable segments: CoRe banking; mortgage banking and the financial holding company. It generates majority of its revenues from its CoRe banking segment.